Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Racial, Ethnic, and Age-Related Disparities in Sedation and Restraint Use for Older Adults in the Emergency Department.
Jivalagian P, Gettel CJ, Smith CM, Robinson L, Brinker M, Shah D, Kumar A, Faustino IV, Nath B, Chang-Sing E, Taylor RA, Kennedy M, Hwang U, Wong AH. Jivalagian P, et al. Among authors: brinker m. Am J Geriatr Psychiatry. 2025 Jan;33(1):1-14. doi: 10.1016/j.jagp.2024.07.004. Epub 2024 Jul 8. Am J Geriatr Psychiatry. 2025. PMID: 39054237
Formative evaluation of an emergency department clinical decision support system for agitation symptoms: a study protocol.
Wong AH, Nath B, Shah D, Kumar A, Brinker M, Faustino IV, Boyce M, Dziura JD, Heckmann R, Yonkers KA, Bernstein SL, Adapa K, Taylor RA, Ovchinnikova P, McCall T, Melnick ER. Wong AH, et al. Among authors: brinker m. BMJ Open. 2024 Feb 19;14(2):e082834. doi: 10.1136/bmjopen-2023-082834. BMJ Open. 2024. PMID: 38373857 Free PMC article.
Initial Decline in Glomerular Filtration Rate With Finerenone in HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF.
Matsumoto S, Jhund PS, Henderson AD, Bauersachs J, Claggett BL, Desai AS, Brinker M, Schloemer P, Viswanathan P, Mares JW, Scalise A, Lam CSP, Linssen GCM, Kerr Saraiva JF, Senni M, Troughton R, Udell JA, Voors AA, Zannad F, Pitt B, Vaduganathan M, Solomon SD, McMurray JJV. Matsumoto S, et al. Among authors: brinker m. J Am Coll Cardiol. 2025 Jan 21;85(2):173-185. doi: 10.1016/j.jacc.2024.11.020. J Am Coll Cardiol. 2025. PMID: 39814476 Clinical Trial.
Finerenone and Kidney Outcomes in Patients With Heart Failure: The FINEARTS-HF Trial.
Mc Causland FR, Vaduganathan M, Claggett BL, Kulac IJ, Desai AS, Jhund PS, Henderson AD, Brinker M, Perkins R, Scheerer MF, Schloemer P, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, McMurray JJV, Solomon SD. Mc Causland FR, et al. Among authors: brinker m. J Am Coll Cardiol. 2025 Jan 21;85(2):159-168. doi: 10.1016/j.jacc.2024.10.091. Epub 2024 Oct 25. J Am Coll Cardiol. 2025. PMID: 39490700 Free article. Clinical Trial.
Author Correction: Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes.
Vaduganathan M, Filippatos G, Claggett BL, Desai AS, Jhund PS, Henderson A, Brinker M, Kolkhof P, Schloemer P, Lay-Flurrie J, Viswanathan P, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Rossing P, Ruilope LM, Anker SD, Pitt B, Agarwal R, McMurray JJV, Solomon SD. Vaduganathan M, et al. Among authors: brinker m. Nat Med. 2024 Dec;30(12):3778. doi: 10.1038/s41591-024-03372-1. Nat Med. 2024. PMID: 39468366 Free PMC article. No abstract available.
Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure.
Vaduganathan M, Claggett BL, Kulac IJ, Miao ZM, Desai AS, Jhund PS, Henderson AD, Brinker M, Lay-Flurrie J, Viswanathan P, Scheerer MF, Lage A, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, McMurray JJV, Solomon SD. Vaduganathan M, et al. Among authors: brinker m. Circulation. 2025 Jan 14;151(2):149-158. doi: 10.1161/CIRCULATIONAHA.124.072055. Epub 2024 Sep 28. Circulation. 2025. PMID: 39340828 Free PMC article. Clinical Trial.
Finerenone and left ventricular hypertrophy in chronic kidney disease and type 2 diabetes.
Filippatos G, Anker SD, Bakris GL, Rossing P, Ruilope LM, Coats AJS, von Haehling S, Ponikowski P, Rosano GMC, Brinker M, Farjat AE, Roberts L, Pitt B; FIDELIO‐DKD and FIGARO‐DKD investigators. Filippatos G, et al. Among authors: brinker m. ESC Heart Fail. 2024 Sep 3. doi: 10.1002/ehf2.14962. Online ahead of print. ESC Heart Fail. 2024. PMID: 39226189 Free article.
Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes.
Vaduganathan M, Filippatos G, Claggett BL, Desai AS, Jhund PS, Henderson A, Brinker M, Kolkhof P, Schloemer P, Lay-Flurrie J, Viswanathan P, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Rossing P, Ruilope LM, Anker SD, Pitt B, Agarwal R, McMurray JJV, Solomon SD. Vaduganathan M, et al. Among authors: brinker m. Nat Med. 2024 Dec;30(12):3758-3764. doi: 10.1038/s41591-024-03264-4. Epub 2024 Sep 1. Nat Med. 2024. PMID: 39218030 Free PMC article.
183 results